Detection of Soluble ED-A⁺ Fibronectin and Evaluation as Novel Serum Biomarker for Cardiac Tissue Remodeling

Figure 1

Establishment of the specific ELISA for quantification of ED-A⁺ Fn: Evaluation of different ED-A⁺ Fns as molecule for standard quantification (a) and exclusion of cross-reactions to pFn (a), between different components of the ELISA setup (b), and to endogenous immunoglobulins (c).

(a)

(b)

(c)